Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             119 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A challenging case of catatonia during pregnancy Martinez-Sosa, Natalie
11-12 C p.
 artikel
2 A cross-diagnostic study of adherence to ecological momentary assessment: Comparisons across study length and daily survey frequency find that early adherence is a potent predictor of study-long adherence Jones, Sara E.
11-12 C p.
 artikel
3 Acute and six-month depression-related abnormalities in the sleep-wake rhythm of cardiac autonomic activity in survivors of acute coronary syndromes Castro, M.N.
 2017
 11-12 C p. 13-18
 artikel
4 Acute antidepressant effects of deep brain stimulation – Review and data from slMFB-stimulation Bewernick, Bettina H.
 2017
 11-12 C p. 1-7
7 p.
 artikel
5 Adiponectin moderates antidepressant treatment outcome in the combining medications to enhance depression outcomes randomized clinical trial Furman, Jennifer L.
 2018
 11-12 C p. 1-7
 artikel
6 An updated classification of antidepressants: A proposal to simplify treatment Alvano, Sebastian A.
11-12 C p.
 artikel
7 An 8-week open label trial of l-Threonic Acid Magnesium Salt in patients with mild to moderate dementia Wroolie, Tonita E.
 2017
 11-12 C p. 7-12
 artikel
8 Anxiolytic benefits of compounded Atenolol–Scopolamine in eight patients in psychiatry Benjamin, Ashley B.
11-12 C p.
 artikel
9 Apathy and depression: Which clinical specificities? Batail, J.M.
 2018
 11-12 C p. 21-26
 artikel
10 Are modern neuromodulation therapies too precise? McDonald, William M.
11-12 C p. 1-3
 artikel
11 A review of transcranial direct current stimulation (tDCS) for the individualized treatment of depressive symptoms Jog, Mayank V.
11-12 C p. 17-22
 artikel
12 A systematic review of treatments for misophonia Mattson, Seth A.
11-12 C p.
 artikel
13 Autism presenting in the context of a genetic variant of CFTR and early HSV exposure confounded by chronic pain, altered gut microbiota and paternal abandonment; limitations of current pharmacotherapy and barriers to personalized treatment recommendations Deutsch, Stephen I.
 2017
 11-12 C p. 24-29
6 p.
 artikel
14 Autoimmune disorders and postpartum psychosis: Case report with a comprehensive topical review Ganjekar, Sundarnag
 2018
 11-12 C p. 1-6
 artikel
15 Baseline monitoring of atypical antipsychotics at a Family Medicine Teaching Unit (FMTU) in Ontario, Canada Ranpara, Manish
11-12 C p.
 artikel
16 Beyond antidepressant effects of deep brain stimulation – A systematic qualitative approach Ziesen, Nenja K.
11-12 C p.
 artikel
17 Beyond one-size-fits-all: The rise of personalized treatment in schizophrenia Nashwan, Abdulqadir J.
11-12 C p.
 artikel
18 Brain activation induced by psychological stress in nonpsychotic siblings of patients with schizophrenia Castro, M.N.
 2017
 11-12 C p. 74-80
7 p.
 artikel
19 Brain-derived neurotrophic factor (BDNF Val66Met) in borderline personality disorder: Associated with eating disorder comorbidity but not psychotherapy response Lisoway, Amanda
11-12 C p.
 artikel
20 Can probiotics reduce bipolar symptoms?: A systematic review Ahmed, Nida
11-12 C p.
 artikel
21 Characterizing chronic non-suicidal self-injury and other forms of repetitive and escalating suicide behaviour as endocannabinoid-mediated pain and reward disorders Kim, Hye Ji J.
11-12 C p.
 artikel
22 Citalopram is less effective for patients with neurological disorder and/or post-traumatic stress disorder Alemi, Farrokh
 2017
 11-12 C p. 32-38
 artikel
23 Clinical and psychosocial factors affecting outcome with sublingual buprenorphine-naloxone substitution in opioid dependence in terms of abstinence and compliance-A two years longitudinal study Das, Sourav
11-12 C p.
 artikel
24 Clinical utility of pharmacogenetics-guided treatment of depression and anxiety Boland, Joseph R.
 2018
 11-12 C p. 7-13
 artikel
25 Cognitive control circuit function predicts antidepressant outcomes: A signal detection approach to actionable clinical decisions Williams, Leanne M.
11-12 C p.
 artikel
26 Cognitive gene risk profile for the prediction of cognitive decline in presymptomatic Alzheimer’s disease Porter, Tenielle
 2018
 11-12 C p. 14-20
 artikel
27 Cooperative studies Program (CSP) #572: A study of serious mental illness in veterans as a pathway to personalized medicine in schizophrenia and bipolar illness Harvey, Philip D.
11-12 C p.
 artikel
28 Correlation between duration of untreated psychosis and working memory in early-onset psychotic disorders Baskoro, Joko Cahyo
11-12 C p.
 artikel
29 Cranial electrotherapy stimulation in the treatment of posttraumatic stress disorder: A feasibility, safety, and preliminary efficacy study Rustad, James K.
11-12 C p.
 artikel
30 Currently available means to achieve personalized psychiatry Cohen, Bruce M.
11-12 C p.
 artikel
31 CYP2D6 metabolizer status and HTTLPR variant of SLC6A4 associated with antidepressant-induced mania in bipolar disorder Beaupre, Lindsay Melhuish
 2019
 11-12 C p. 6-10
 artikel
32 Deep brain stimulation for treatment-resistant depression: Predicting response and optimizing treatment Conroy, Susan K.
11-12 C p. 43-45
 artikel
33 Defining irritability as a diagnostic marker and a target for responsiveness Bell, Erica
11-12 C p.
 artikel
34 Deiodinase variation and liothyronine treatment interaction to accelerate ECT response in major depression: Pilot data and implications for thyroid pharmacogenomic testing in mood disorders Nuñez, Nicolas A
11-12 C p.
 artikel
35 Depression as a systemic disease Sotelo, Jorge Luis
 2017
 11-12 C p. 11-25
15 p.
 artikel
36 Differences in perceived life stress in bipolar I and II disorder: Implications for future epigenetic quantification Grzenda, Adrienne
11-12 C p.
 artikel
37 Digital revolution in depression: A technologies update for clinicians Lazar, Max A.
 2017
 11-12 C p. 1-6
 artikel
38 Disrupted copper homeostasis: Pathogenic factor in autism spectrum disorder and side effect of valproic acid Deutsch, Stephen I.
11-12 C p.
 artikel
39 Diurnal variation of heart rate variability as a physiological index of mood and emotion regulation processes in Major Depression and Borderline Personality Disorder Wainsztein, Agustina E.
11-12 C p.
 artikel
40 Does gender influence cognitive function in non-psychotic depression? Caldirola, Daniela
 2017
 11-12 C p. 25-31
 artikel
41 Early treatment response affects signal detection in a placebo-controlled depression study Targum, Steven D.
 2017
 11-12 C p. 19-24
 artikel
42 Elucidation of molecular processes and biomarkers linked to the genetic variations driving the etiology of mood disorders Duc Nguyen, Hai
11-12 C p.
 artikel
43 Ethical implementation of precision psychiatry Ball, Tali M.
11-12 C p.
 artikel
44 Expert opinion in Alzheimer disease: The silent scream of patients and their family during coronavirus disease 2019 (COVID-19) pandemic Guinjoan, Salvador M.
11-12 C p.
 artikel
45 Expert opinion in anxiety disorder: Corona-phobia, the new face of anxiety Nardi, Antonio E.
11-12 C p.
 artikel
46 Expert opinion in bipolar disorder: Impact of COVID-19 on outcomes and treatment of bipolar disorder Spelber, David
11-12 C p.
 artikel
47 Expert opinion in mental disorder: Why is acceptance of the COVID-19 vaccines so problematic? Gorman, Jack M.
11-12 C p.
 artikel
48 Expert opinion in Obsessive-Compulsive Disorder: Could protective measures for COVID-19 contribute to the worsening of OCD symptoms? Baldi, Samantha
11-12 C p.
 artikel
49 Expert opinion in obsessive-compulsive disorder: Treating patients with obsessive-compulsive disorder during the COVID-19 pandemic Candelari, Abigail E.
11-12 C p.
 artikel
50 Expert opinion in panic disorder: The impact of COVID-19-related fears, protective devices, and lockdown on panic and agoraphobia Caldirola, Daniela
11-12 C p.
 artikel
51 Expert opinion in psychotherapy: The transformation of psychotherapy practice in the Covid-19 era Gabbard, Glen O.
11-12 C p.
 artikel
52 Free testosterone is associated with perceived stress in women Flores-Ramos, Mónica
11-12 C p.
 artikel
53 Glutamate modulators for treatment of schizophrenia Zhand, Naista
 2019
 11-12 C p. 1-12
 artikel
54 Glycogen synthase kinase3β: A key player of cognitive dysfunction in chronic kidney disease patients and a possible link between abnormal pTau and platelet APP processing and therapeutic role of erythropoietin Vinothkumar, G.
11-12 C p.
 artikel
55 Health disparities in the treatment of bipolar disorder Tchikrizov, Vladimir
11-12 C p.
 artikel
56 Identification of biotypes in Attention-Deficit/Hyperactivity Disorder, a report from a randomized, controlled trial Leikauf, John E.
 2017
 11-12 C p. 8-17
10 p.
 artikel
57 Identification of clinical features and biomarkers that may inform a personalized approach to rTMS for depression Garnaat, Sarah L.
11-12 C p. 4-16
 artikel
58 Impact of morbid obesity on treatment outcome in a clinical trial of major depressive disorder Targum, Steven D.
 2017
 11-12 C p. 18-23
6 p.
 artikel
59 Impaired meaning-based cognitive skills are specifically associated with poorer subjective quality of life in schizophrenia Tan, Eric J.
11-12 C p.
 artikel
60 Improvement of stuttering after administration of methylphenidate - a case report SheikhBahaei, Shahriar
11-12 C p.
 artikel
61 Improving therapy outcome prediction in major depression using multimodal functional neuroimaging: A pilot study Schultz, Johannes
 2018
 11-12 C p. 7-15
 artikel
62 Individual cognitive and depressive traits associated with maternal versus paternal family history of Late-onset Alzheimer’s disease: Proactive semantic interference versus standard neuropsychological assessments Wilson, Kathleen E.
 2018
 11-12 C p. 1-6
 artikel
63 Individualized theta-burst stimulation modulates hippocampal activity and connectivity in patients with major depressive disorder Mielacher, Clemens
11-12 C p.
 artikel
64 Integrated mental health and HIV care in a majority minority clinic Echenique, Marisa
 2019
 11-12 C p. 1-5
 artikel
65 Integrating genetic variation with DNA methylation at SKA2 rs7208505 in analyses of obsessive-compulsive disorder disease risk and symptom severity Lisoway, Amanda J.
11-12 C p.
 artikel
66 Irritability in a mixed sample of patients with unipolar and bipolar II depression predicts responsiveness to lamotrigine Peters, Evyn M.
 2018
 11-12 C p. 27-30
 artikel
67 Left versus right subcallosal cingulate deep brain stimulation for treatment-resistant depression Conroy, Susan K.
11-12 C p.
 artikel
68 Lifetime history of childhood adversity and substance abuse in patients with treatment resistant depression Giampetruzzi, Eugenia
11-12 C p.
 artikel
69 Low-dose lithium impact in an addiction treatment setting Gadh, Sudhir
11-12 C p.
 artikel
70 Low dose pipamperone therapy for major depression: A randomized controlled clinical trial comparison with citalopram Buntinx, Erik
11-12 C p.
 artikel
71 Magnetic seizure therapy: Towards personalized seizure therapy for major depression Kallioniemi, Elisa
11-12 C p. 37-42
 artikel
72 Manic symptoms in the context of anti-thyroid antibodies and letrozole infertility treatment Dlugolecki, Leah M.
 2019
 11-12 C p. 19-21
 artikel
73 Measurement invariance of the Childhood Trauma Questionnaire by gender, poverty level, and HIV status Rodriguez, Violeta J.
 2018
 11-12 C p. 16-22
 artikel
74 Mental health of young researchers in academia: Towards to growth perspective Di Giacomo, Dina
11-12 C p.
 artikel
75 Monosodium glutamate influences depressive behavior of two age groups of mice in forced swimming test: Vitamin B6 could remedy the situation Mesripour, Azadeh
 2019
 11-12 C p. 28-32
 artikel
76 Multimodal phenotyping of psychiatric disorders from social interaction: Protocol of a clinical multicenter prospective study König, Alexandra
11-12 C p.
 artikel
77 Neurocognitive impairment in patients with comorbid diabetes mellitus and depression Padilla, Vanessa L.
 2017
 11-12 C p. 2-10
9 p.
 artikel
78 Open-label pilot study of psychiatric pharmacogenetic testing in an adult psychiatric inpatient population King, Christopher D.
11-12 C p.
 artikel
79 Options when anti-depressants cannot be used in conventional ways. Clinical case and review of literature Das, Aparna
 2019
 11-12 C p. 22-27
 artikel
80 Outside the typical anxiety disorder definition: Characterizing the role of impulsivity in comorbid substance use disorder Tomasi, Julia
 2019
 11-12 C p. 13-21
 artikel
81 Peripheral kynurenines as biomarkers and targets for prevention and treatment of psychiatric conditions associated with SARS-CoV-2 infection Oxenkrug, Gregory
11-12 C p.
 artikel
82 Perphenazine-induced sialorrhea successfully treated with sublingual atropine: A case report Lee, Heather Fiona
 2019
 11-12 C p. 22-24
 artikel
83 Personalized definition of surgical targets in major depression and obsessive-compulsive disorder: A potential role for low-intensity focused ultrasound? Guinjoan, Salvador M.
11-12 C p.
 artikel
84 Personalized functional connectivity analysis in responders and nonresponders to ketamine and electroconvulsive therapy: A case series Fazzito, Maria Lucia
11-12 C p.
 artikel
85 Personalized medicine in panic disorder: where are we now? A meta-regression analysis Caldirola, Daniela
 2017
 11-12 C p. 26-38
13 p.
 artikel
86 Personalized Medicine in Psychiatry: Back to the Future Perna, Giampaolo
 2017
 11-12 C p. 1-
1 p.
 artikel
87 Personalizing antidepressant choice by sex, body mass index, and symptom profile: An iSPOT-D report Green, Erin
 2017
 11-12 C p. 65-73
9 p.
 artikel
88 Precision ECT for major depressive disorder: A review of clinical factors, laboratory, and physiologic biomarkers as predictors of response and remission Yao, Zhixing
11-12 C p. 23-31
 artikel
89 Predicting subjective quality of life and illness impact for individuals with schizophrenia using the Five-Factor Model of personality: A starting point for future research Rogers, Russell T.
11-12 C p.
 artikel
90 Predictors of response for vagus nerve stimulation in treatment-resistant depression de Leon, V.C.
11-12 C p. 32-36
 artikel
91 Predictors of response to intranasal ketamine in patients hospitalized for treatment-resistant depression Peters, Evyn M.
11-12 C p.
 artikel
92 Preliminary insights into the genetic architecture of postpartum depressive symptom severity using polygenic risk scores Pouget, Jennie G.
11-12 C p.
 artikel
93 Protocolization as a method of addressing heterogeneity in electroconvulsive therapy delivery Stone, Jordan
11-12 C p.
 artikel
94 Publisher Note
11-12 C p.
 artikel
95 Putative biological predictors of treatment response in bipolar disorders Gonzalez, Suzanne D.
 2017
 11-12 C p. 39-58
20 p.
 artikel
96 Putative novel neuromodulatory treatments for affective disorders – What might emerge? Kilian, Hannah M.
11-12 C p. 46-50
 artikel
97 Qualitative treatment-subgroup interactions in the antidepressant treatment of major depression: Application of QUINT to individual participant data from seven placebo-controlled randomized controlled trials Maruo, Kazushi
11-12 C p.
 artikel
98 Randomized, Placebo-controlled, Antidepressant Treatment of Patients with Major Depressive Disorder: Changes in Glomerular Filtration Rate Claros-Erazo, Melissa
11-12 C p.
 artikel
99 Repetitive negative thinking is associated with impaired verbal learning but not executive functioning in individuals with eating disorders Cardenas, Grace E.
11-12 C p.
 artikel
100 SCL6A4 polymorphisms rs25533 and I425V: Association with obsessive–compulsive disorder and its treatment response in Iranian patients Ahmadipour, Ehsan
 2018
 11-12 C p. 23-29
 artikel
101 Special issue editorial: Personalized medicine in psychiatry in the COVID-19 era: Fighting the impact of the pandemic on mental health Perna, Giampaolo
11-12 C p.
 artikel
102 Subjective impact of COVID-19 pandemic on youth with tic and OCD spectrum disorders Tomczak, Kinga K.
11-12 C p.
 artikel
103 Substance use disorders in schizophrenia: Prevalence, etiology, biomarkers, and treatment Ward, Heather Burrell
11-12 C p.
 artikel
104 Symptom provocation to enhance the treatment effect of transcranial magnetic stimulation for obsessive compulsive disorder—A systematic review, evaluation and discussion Liu, Lucia B.
11-12 C p.
 artikel
105 T3 augmentation in major depressive disorder: Sex and age differences Hajnas, Natalia
11-12 C p.
 artikel
106 Ten-year patterns of psychiatric medications dispensed to adolescent in Finland: Open dialogue-informed practice in Western Lapland as compared to practice in other Finnish regions Valtanen, Kari
11-12 C p.
 artikel
107 The multi-modal treatment of catatonia: Targeting multiple receptors when GABA-based benzodiazepines fail Veluri, Nikhila
11-12 C p.
 artikel
108 The narrative crisis model of suicide: A review of empirical evidence for an innovative dynamic model of suicide and a comparison with other theoretical frameworks Bloch-Elkouby, Sarah
11-12 C p.
 artikel
109 The narrative crisis model of suicide as a framework for suicide prevention Rogers, Megan L.
11-12 C p.
 artikel
110 The relationship between circadian gene single nucleotide polymorphisms and clinical and behavioral assessments of sleep and rhythms and course of illness characteristics in subjects with bipolar type I disorder Gonzalez, Robert
 2019
 11-12 C p. 11-18
 artikel
111 The structure of personality disorders within a depressed sample: Implications for personalizing treatment Berg, Joanna M.
 2017
 11-12 C p. 59-64
6 p.
 artikel
112 The temporal dynamics of daily stress, affect, and several affect regulation processes, in patients with chronic mood and anxiety disorders before and after a mindful yoga intervention Vollbehr, Nina K.
11-12 C p.
 artikel
113 The Texas child mental health network: A child and adolescent research registry Tamminga, Carol A.
11-12 C p.
 artikel
114 The United States index of socioeconomic deprivation for individuals (USiDep) Dunlop, Boadie W.
11-12 C p.
 artikel
115 The use of machine learning and deep learning models in detecting depression on social media: A systematic literature review Gadzama, Wadzani Aduwamai
11-12 C p.
 artikel
116 Using empathy to prevent burnout treating patients with cluster B personality disorders in psychiatry residency: A case study in context Derrick Knox, LT
11-12 C p.
 artikel
117 Utilizing a transdiagnostic neuroscience-informed approach to differentiate the components of a complex clinical presentation: A case report Vanden Bussche, Alicia B.
 2017
 11-12 C p. 30-37
8 p.
 artikel
118 Withdrawal symptoms after discontinuation of a noradrenergic and specific serotonergic antidepressant: A case report and review of the literature Cosci, Fiammetta
 2017
 11-12 C p. 81-84
4 p.
 artikel
119 Ziconotide-induced psychosis in patient without previous psychiatric history: A case report Su, Amanda
11-12 C p.
 artikel
                             119 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland
Toegankelijkheidsverklaring